Publication|Articles|August 12, 2024
- Pharmaceutical Commerce - August 2024
- Volume 19
- Issue 4
Pharmaceutical Commerce - August 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce August 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Taking Inventoryalmost 2 years ago
A Journey of the Mindalmost 2 years ago
Pharmacy Deserts are Becoming a National Problemalmost 2 years ago
An Examination of Big Pharma Inventoriesalmost 2 years ago
The IRA’s Impact on Patient Hub, Access, and Affordability Programsalmost 2 years ago
US Drug Wholesaling 2024: Staying the Coursealmost 2 years ago
Biotech’s Achilles’ Heelalmost 2 years ago
Looking Ahead to Medicare Reforms Coming in 2025Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the US Section 301 Probe Targets Germany's Drug Pricing
2
Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?
3
Report: GLP-1s, Oncology to Drive Drug Spending Surge in 2027
4
How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure
5